Viewing Study NCT00518193


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-02-17 @ 6:35 PM
Study NCT ID: NCT00518193
Status: TERMINATED
Last Update Posted: 2011-06-30
First Post: 2007-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix
Sponsor: ARCAGY/ GINECO GROUP
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module